Janet Woodcock and COVID-19 Vaccine

Selected healthcare news for the person - Janet Woodcock, and the healthcare topic - COVID-19 Vaccine. We have 291 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/11/2022 5 questions facing the FDA in 2022 | BioPharma Dive ... face a long to-do list, especially when the position goes unfilled for as long as it did this time. Janet Woodcock, who has served as acting commissioner, is an experienced leader and known quantity ... cadence of drug approval decisions and the ongoing reviews of COVID-19 vaccines and treatments.The continuing pandemic is a constant reminder of the position's importance. "This administration has left the FDA commissioner position open ...
12/14/2021 Coronavirus Today : What does it mean to be 'fully vaccinated'? - Los Angeles Times LA Times ... COVID-19 vaccines, it‚Aos COVID-19 booster shots .Dr. Anthony Fauci , President Biden‚Aos senior advisor on the pandemic: ‚AuOptimal protection is going to be with a third shot.‚AuAdvertisement Dr. Rochelle Walensky , director of the Centers for Disease Control and Prevention: ‚AuCDC is strengthening its booster recommendations and encouraging everyone 16 and older to receive a booster shot.‚AuDr. Janet Woodcock , acting Food and Drug Administration ...
11/30/2021 U.S. FDA evaluating effectiveness of COVID-19 vaccines against Omicron Reuters) ‚Ai The U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against the Omicron coronavirus variant and expects to have more information in the next few weeks.The agency is currently evaluating the vaccines to see if and how well they work against the variant, first detected in South Africa, Acting Commissioner Janet Woodcock said in a statement.She said if ...
11/30/2021 U.S. FDA evaluating effectiveness of COVID-19 vaccines against Omicron Reuters) - The U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against the Omicron coronavirus variant and expects to have more information in the next few weeks.The agency is currently evaluating the vaccines to see if and how well they work against the variant, first detected in South Africa, Acting Commissioner Janet Woodcock said in a statement.She said if the ...
11/30/2021 US FDA evaluating effectiveness of COVID-19 vaccines against Omicron - The Jerusalem Post The US Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against the Omicron coronavirus variant and expects to have more information in the next few weeks. The agency is currently evaluating the vaccines to see if and how well they work against the variant, first detected in South Africa, Acting Commissioner Janet Woodcock said in a statement. She said if the review ...
11/30/2021 U.S. FDA evaluating effectiveness of COVID-19 vaccines against Omicron U.S. FDA evaluating effectiveness of COVID-19 vaccines against OmicronNovember 30, 2021; 11:21 AM EST(Reuters) ‚Ai The U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 ... against the variant, first detected in South Africa, Acting Commissioner Janet Woodcock said in a statement.She said if the review shows a modification to the current vaccines is needed, the agency and companies will ...
11/30/2021 U.S. FDA evaluating effectiveness of COVID-19 vaccines against Omicron -Breaking Reuters) ‚Ai The U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against the Omicron coronavirus variant and expects to have more information in the next few weeks.Janet Woodcock, acting commissioner, stated that the agency was currently testing vaccines in order to determine if they are effective against the variant first identified in South Africa.According to her, if the reviews ...
11/30/2021 U.S. FDA Evaluating Effectiveness of COVID-19 Vaccines Against Omicron | Top News | US News U.S. News & World Report ... COVID-19 vaccines against the Omicron coronavirus variant and expects to have more information in the next few weeks.The agency is currently evaluating the vaccines to see if and how well they work against the variant, first detected in South Africa, Acting Commissioner Janet Woodcock said in a statement.She said if the review shows a modification to the current vaccines is needed, the agency and companies will work ...
11/30/2021 FDA evaluating effectiveness of COVID-19 vaccines against Omicron The U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against the Omicron coronavirus variant and expects to have more information in the next few weeks.The agency is currently evaluating the vaccines to see if and how well they work against the variant, first detected in South Africa, Acting Commissioner Janet Woodcock said in a statement.She said if the review ...
11/30/2021 U.S. FDA evaluating effectiveness of COVID-19 vaccines against Omicron Reuters) ‚Ai The U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against the Omicron coronavirus variant and expects to have more information in the next few weeks.The agency is currently evaluating the vaccines to see if and how well they work against the variant, first detected in South Africa, Acting Commissioner Janet Woodcock said in a statement.She said if ...
8/19/2021 Will Johnson & Johnson COVID-19 vaccine recipients need booster too? ... for booster shots laid out by health officials on Wednesday applies to Americans who received both doses of an mRNA COVID-19 vaccine , but for the nearly 14 million who received Johnson & Johnson‚Aos one ... Dr. Rochelle Walensky, Dr. Anthony Fauci, the FDA‚Aos Dr. Janet Woodcock and others, said. ‚AuAdministration of the J&J vaccine did not begin in the U.S. until March 2021, and we expect more data ...
8/19/2021 Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots ... people. The statement is attributable to Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC); Dr. Janet Woodcock, Acting Commissioner, Food and Drug Administration (FDA); Dr. Vivek Murthy, U.S. Surgeon General ... Chair of the COVID-19 Health Equity Task Force: ‚AuThe COVID-19 vaccines authorized in the United States continue to be remarkably effective in reducing risk of severe disease, hospitalization, and death, even against the ...
8/18/2021 Rush to Boosters Sparks Confusion, Differing Recommendations Kaiser Health News ... covid-19 vaccine may boost the immunity of some people who are immunocompromised, officials repeated their stance that fully vaccinated, healthy people do not need another dose. With this caveat: ‚AuThe FDA is actively engaged in a science-based, rigorous process with our federal partners to consider whether an additional dose may be needed in the future,‚Au said acting FDA Commissioner Dr. Janet Woodcock. But the Biden administration reportedly ...
8/16/2021 FDA Permits Booster Shots for People with Immunocompromised ... COVID-19 vaccines by Pfizer Inc. and Moderna Inc. , paving the way for people who have had an organ transplant, or those with a similar level of the weakened immune system, to get an extra dose of the same shot they have initially received. According to FDA Commissioner Dr. Janet Woodcock , ‚AuToday‚Aos action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID-19 ...
8/16/2021 CVS, Walgreens offer COVID booster dose to certain immunocompromised patients Walgreens and CVS are administering a third dose of the COVID-19 vaccine to certain immunocompromised patients after federal health officials said the extra shot would "boost" their immunity as the delta variant continues to ... immunocompromised individuals who need extra protection from COVID-19," Dr. Janet Woodcock, the FDA‚Aos acting commissioner, said in a statement.Walgreens says the shots will be given to patients who are "moderately to severely immunocompromised ...
8/15/2021 CDC approval of Covid booster shot provides assist for some Individuals U.S. well being businesses gave the go-ahead for immunocompromised folks to obtain a 3rd dose of the Covid-19 vaccine late Thursday night time, a excessive observe amidst more and more alarming information in ... are significantly in danger for extreme illness,‚Au mentioned Dr. Janet Woodcock, the appearing FDA commissioner, in a press release associated to the announcement. ‚AuAfter a radical overview of the obtainable information, the FDA decided ...
8/13/2021 FDA Approves Third COVID Vaccine Dose for Immunocompromised New York Mag The Food and Drug Administration authorized an additional COVID-19 vaccine dose from Pfizer or Moderna for certain immunocompromised people on Thursday. The decision comes as the supercharged Delta variant fuels a resurgence in cases ... are particularly at risk for severe disease,‚Au FDA commissioner Janet Woodcock said in a statement . ‚AuAfter a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from ...
7/31/2021 What Would Full FDA Approval of Pfizer's COVID Vaccine Mean for the Stock? @themotleyfool #stocks $PFE $BNTX The clock is now ticking for a Food and Drug Administration decision on full approval for the COVID-19 vaccine developed by Pfizer ( NYSE:PFE ) and BioNTech ( NASDAQ:BNTX ). The vaccine is currently on the ... six months with this approval decision. The acting FDA commissioner, Janet Woodcock, has already said that the FDA hopes to make a decision well before the goal date. The question is, "How soon will it ...
7/30/2021 FDA Puts All Hands on Deck to Review Pfizer-BioNTech Covid Shot Bloomberg ... in order to complete our review to help combat this pandemic surge,‚Au agency spokesperson Abby Capobianco said. Acting Director Janet Woodcock has ‚Auoffered all agency resources to the team to make this happen,‚Au ... activities. ‚AuWe recognize that for some, the FDA approval of Covid-19 vaccines may bring additional confidence and encourage them to get vaccinated,‚Au Capobianco said in the statement. ‚AuFDA staff will conduct a thorough ...
7/22/2021 Feds wait for lowered vaccine efficacy to recommend COVID-19 booster shots McKnight's Long Term Care News COVID-19 vaccine booster shots will not be necessary until mRNA vaccines become less effective, federal health officials say. But immunocompromised Americans are on their radar as potential near-term recipients, they told U.S. senators ... currently approved under emergency use authorization only, FDA acting chief Janet Woodcock said, according to ABC News. Health officials said they also were waiting for Pfizer to deliver its clinical data on booster shots. In ...
7/16/2021 UPDATE 1-U.S. FDA sets January target to decide on approval of Pfizer's COVID-19 shot Yahoo News Adds FDA comment) July 16 (Reuters) - The U.S. health regulator will review Pfizer and German partner BioNTech SE's application for full approval of their COVID-19 vaccine in people 16 years and older by January, the companies said on Friday. The target action date does not mean the approval will not happen before January, the U.S. Food and Drug Administration's Acting Commissioner Janet Woodcock said on Twitter. (https://bit.ly/36Ixfkm ...
7/16/2021 U.S. FDA sets January target to decide on approval of Pfizer's COVID-19 shot - Netscape News 07/16/2021 18:47 (Reuters) -The U.S. health regulator will review Pfizer and German partner BioNTech SE's application for full approval of their COVID-19 vaccine in people 16 years and older by January, the companies said on Friday.The target action date does not mean the approval will not happen before January, the U.S. Food and Drug Administration's Acting Commissioner Janet Woodcock said on Twitter. (https://bit.ly/36Ixfkm)"Quite to the ...
7/14/2021 Ron Johnson Presses Biden to Monitor Reactions to Coronavirus Vaccines Breitbart ... Francis Collins, Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky, and Food and Drug Administration (FDA) Acting Commissioner Janet Woodcock, asking about the agencies‚Ao efforts to monitor and report about adverse reactions ... as one of the primary passive surveillance tools for monitoring COVID-19 vaccine safety. CDC highlighted that VAERS covered the entire U.S. population and its ability to ‚Aorapidly detect safety signals‚Ao and ‚Aodetect rare ...
7/7/2021 Coronavirus (COVID-19) Update: July 6, 2021 For Immediate Release: The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: - On Thursday, June 29, 2021, Acting FDA Commissioner Janet Woodcock, M.D. and the Director of FDA‚Aos Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., discussed the updates on myocarditis and pericarditis following vaccination with the Pfizer-BioNTech or Moderna COVID-19 Vaccines ...
7/7/2021 Coronavirus (COVID-19) Update: July 6, 2021 | FDA ‚Äì FDA.gov ... Janet Woodcock, M.D. and the Director of FDA‚Aos Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., discussed the updates on myocarditis and pericarditis following vaccination with the Pfizer-BioNTech or Moderna COVID-19 Vaccines during a stakeholder call with Vaccinate Your Family and pediatric and healthcare groups. To watch and listen to the call, visit FDA‚Aos YouTube channel . Testing updates: As of today, 393 tests and ...